403 related articles for article (PubMed ID: 21076461)
41. Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas.
Ehrlich D; Bruder E; Thome MA; Gutt CN; von Knebel Doeberitz M; Niggli F; Perantoni AO; Koesters R
Pediatr Dev Pathol; 2010; 13(1):1-8. PubMed ID: 19348510
[TBL] [Abstract][Full Text] [Related]
42. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
[TBL] [Abstract][Full Text] [Related]
43. Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.
Borcherding N; Cole K; Kluz P; Jorgensen M; Kolb R; Bellizzi A; Zhang W
Am J Pathol; 2018 Aug; 188(8):1910-1920. PubMed ID: 29879416
[TBL] [Abstract][Full Text] [Related]
44. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
45. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course.
Akhoundova D; Fischer S; Triscott J; Lehner M; Thienger P; Maletti S; Jacquet M; Lubis DSH; Bubendorf L; Jochum W; Rubin MA
Diagn Pathol; 2024 Jun; 19(1):83. PubMed ID: 38907236
[TBL] [Abstract][Full Text] [Related]
46. Wnt signaling in triple negative breast cancer is associated with metastasis.
Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival.
Maharjan R; Backman S; Åkerström T; Hellman P; Björklund P
Sci Rep; 2018 Jun; 8(1):8610. PubMed ID: 29872083
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
49. β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma.
Gaujoux S; Grabar S; Fassnacht M; Ragazzon B; Launay P; Libé R; Chokri I; Audebourg A; Royer B; Sbiera S; Vacher-Lavenu MC; Dousset B; Bertagna X; Allolio B; Bertherat J; Tissier F
Clin Cancer Res; 2011 Jan; 17(2):328-36. PubMed ID: 21088256
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
[TBL] [Abstract][Full Text] [Related]
51. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
[TBL] [Abstract][Full Text] [Related]
52. β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma).
Suzuki Y; Ichihara S; Kawasaki T; Yanai H; Kitagawa S; Shimoyama Y; Nakamura S; Nakaguro M
Virchows Arch; 2018 Aug; 473(2):235-239. PubMed ID: 29736797
[TBL] [Abstract][Full Text] [Related]
53. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
54. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
55. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
56. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract][Full Text] [Related]
57. β-Catenin alterations in testicular Leydig cell tumour: a immunohistochemical and molecular analysis.
Kitagawa Y; De Biase D; Ricci C; Cornejo KM; Fiorentino M; Collins K; Idrees MT; Colecchia M; Ulbright TM; Acosta AM
Histopathology; 2024 Jul; 85(1):75-80. PubMed ID: 38530207
[TBL] [Abstract][Full Text] [Related]
58. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
59. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
60. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]